109 related articles for article (PubMed ID: 9240248)
1. Changes in atherogenic lipids and lipoproteins during natural and hyperstimulated cycles in healthy women.
Haines CJ; Cheung LP; Lam CW
Fertil Steril; 1997 Aug; 68(2):231-5. PubMed ID: 9240248
[TBL] [Abstract][Full Text] [Related]
2. Differences in serum lipids, lipoproteins, sex hormone binding globulin and testosterone between the follicular and the luteal phase of the menstrual cycle.
Schijf CP; van der Mooren MJ; Doesburg WH; Thomas CM; Rolland R
Acta Endocrinol (Copenh); 1993 Aug; 129(2):130-3. PubMed ID: 8372597
[TBL] [Abstract][Full Text] [Related]
3. Lipoprotein(a) changes during natural menstrual cycle and ovarian stimulation with recombinant and highly purified urinary FSH.
Ricci G; Tamaro G; Simeone R; Giolo E; Nucera G; De Seta F; Guaschino S
Hum Reprod; 2001 Mar; 16(3):449-56. PubMed ID: 11228210
[TBL] [Abstract][Full Text] [Related]
4. Atypical estradiol secretion and ovulation patterns caused by luteal out-of-phase (LOOP) events underlying irregular ovulatory menstrual cycles in the menopausal transition.
Hale GE; Hughes CL; Burger HG; Robertson DM; Fraser IS
Menopause; 2009; 16(1):50-9. PubMed ID: 18978637
[TBL] [Abstract][Full Text] [Related]
5. Variation of lipids and lipoproteins in premenopausal women compared with men and postmenopausal women. DELTA (Dietary Effects on Lipoproteins and Thrombogenic Activity) Investigators.
Reed RG; Kris-Etherton P; Stewart PW; Pearson TA
Metabolism; 2000 Sep; 49(9):1101-5. PubMed ID: 11016887
[TBL] [Abstract][Full Text] [Related]
6. Triggering of ovulation in human menopausal gonadotrophin-stimulated cycles: comparison between intravenously administered gonadotrophin-releasing hormone (100 and 500 micrograms), GnRH agonist (buserelin, 500 micrograms) and human chorionic gonadotrophin (10,000 IU).
Gerris J; De Vits A; Joostens M; Van Royen E
Hum Reprod; 1995 Jan; 10(1):56-62. PubMed ID: 7745071
[TBL] [Abstract][Full Text] [Related]
7. Plasma lipid and lipoprotein levels during the follicular and luteal phases of the menstrual cycle.
Barnett JB; Woods MN; Lamon-Fava S; Schaefer EJ; McNamara JR; Spiegelman D; Hertzmark E; Goldin B; Longcope C; Gorbach SL
J Clin Endocrinol Metab; 2004 Feb; 89(2):776-82. PubMed ID: 14764796
[TBL] [Abstract][Full Text] [Related]
8. Interruption of endometrial maturation without hormonal changes by an antiprogesterone during the first half of luteal phase of the menstrual cycle: a contraceptive potential.
Greene KE; Kettel LM; Yen SS
Fertil Steril; 1992 Aug; 58(2):338-43. PubMed ID: 1633899
[TBL] [Abstract][Full Text] [Related]
9. The luteal phase of nonsupplemented cycles after ovarian superovulation with human menopausal gonadotropin and the gonadotropin-releasing hormone antagonist Cetrorelix.
Albano C; Grimbizis G; Smitz J; Riethmüller-Winzen H; Reissmann T; Van Steirteghem A; Devroey P
Fertil Steril; 1998 Aug; 70(2):357-9. PubMed ID: 9696235
[TBL] [Abstract][Full Text] [Related]
10. Plasma melatonin profile and hormonal interactions in the menstrual cycles of anovulatory infertile women treated with gonadotropins.
Tang PL; Chan TY; Tang GW; Pang SF
Gynecol Obstet Invest; 1998; 45(4):247-52. PubMed ID: 9623790
[TBL] [Abstract][Full Text] [Related]
11. Effect of clomiphene citrate on follicular and luteal phase luteinizing hormone concentrations in in vitro fertilization cycles stimulated with gonadotropins and gonadotropin-releasing hormone antagonist.
Tavaniotou A; Albano C; Smitz J; Devroey P
Fertil Steril; 2002 Apr; 77(4):733-7. PubMed ID: 11937125
[TBL] [Abstract][Full Text] [Related]
12. Doppler study of arterial and venous intraovarian blood flow in stimulated cycles.
Mercé LT; Bau S; Bajo JM
Ultrasound Obstet Gynecol; 2001 Nov; 18(5):505-10. PubMed ID: 11844173
[TBL] [Abstract][Full Text] [Related]
13. alpha-Tocopherol concentrations in plasma but not in lipoproteins fluctuate during the menstrual cycle in healthy premenopausal women.
Lanza E; Forman MR; Johnson EJ; Muesing RA; Graubard BI; Beecher GR
J Nutr; 1998 Jul; 128(7):1150-5. PubMed ID: 9649599
[TBL] [Abstract][Full Text] [Related]
14. Cyclical variation of plasma lipids, apolipoproteins, and lipoprotein(a) during menstrual cycle of normal women.
Tonolo G; Ciccarese M; Brizzi P; Milia S; Dessole S; Puddu L; Secchi G; Maioli M
Am J Physiol; 1995 Dec; 269(6 Pt 1):E1101-5. PubMed ID: 8572203
[TBL] [Abstract][Full Text] [Related]
15. Variations in serum lipids and lipoproteins throughout the menstrual cycle.
Ahumada Hemer H; Valles de Bourges V; Juarez Ayala J; Brito G; Díaz-Sánchez V; Garza-Flores J
Fertil Steril; 1985 Jul; 44(1):80-4. PubMed ID: 4007194
[TBL] [Abstract][Full Text] [Related]
16. Safety and efficacy of low dose hCG for luteal support after triggering ovulation with a GnRH agonist in cases of polyfollicular development.
Krause BT; Ohlinger R
Eur J Obstet Gynecol Reprod Biol; 2006 May; 126(1):87-92. PubMed ID: 16377065
[TBL] [Abstract][Full Text] [Related]
17. Regulation of ovarian follicular and luteal function during treatment with exogenous gonadotropins in anovulatory infertility.
Yuen BH; Sy L; Cannon W
Am J Obstet Gynecol; 1981 Jul; 140(6):629-35. PubMed ID: 6167169
[TBL] [Abstract][Full Text] [Related]
18. Effect of menstrual cycle phase on plasma lipids.
Woods M; Schaefer EJ; Morrill A; Goldin BR; Longcope C; Dwyer JD; Gorbach SL
J Clin Endocrinol Metab; 1987 Aug; 65(2):321-3. PubMed ID: 3597711
[TBL] [Abstract][Full Text] [Related]
19. Relationship between symptom severity and hormone changes in women with premenstrual syndrome.
Hammarbäck S; Damber JE; Bäckström T
J Clin Endocrinol Metab; 1989 Jan; 68(1):125-30. PubMed ID: 2491857
[TBL] [Abstract][Full Text] [Related]
20. Anti-Müllerian hormone: correlation of early follicular, ovulatory and midluteal levels with ovarian response and cycle outcome in intracytoplasmic sperm injection patients.
Elgindy EA; El-Haieg DO; El-Sebaey A
Fertil Steril; 2008 Jun; 89(6):1670-6. PubMed ID: 17658520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
